9 studies found for:    "antithrombin deficiency"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Study of KW-3357 in Congenital Antithrombin Deficiency
Condition: Congenital Antithrombin Deficiency
Intervention: Drug: KW-3357
2 Completed
Has Results
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
Condition: Antithrombin III Deficiency
Intervention: Biological: Recombinant human antithrombin (rhAT)
3 Completed
Has Results
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
Condition: Antithrombin Deficiency, Congenital
Intervention: Biological: Recombinant Human Antithrombin (rhAT)
4 Recruiting Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
Condition: Antithrombin III Deficiency
Intervention: Drug: Plasma-derived AT-III concentrate
5 Recruiting "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
Conditions: Congenital Heart Diseases;   Conotruncal Defects;   Congenital Disorder of Glycosylation;   Antithrombin III Deficiency
Intervention: Other: none intervention
6 Recruiting Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery
Condition: ATIII Deficiency
Interventions: Drug: Anti-thrombin III;   Other: Placebo
7 Not yet recruiting Atenativ Effect on Uterine Blood Flow and Preeclampsia
Condition: Antithrombin III Deficiency
Intervention: Drug: Atenativ
8 Completed Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
Conditions: Acquired Antithrombin III Deficiency;   Coronary Artery Bypass
Intervention: Drug: Antithrombin III
9 Terminated
Has Results
Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
Condition: Thrombophilia Due to Acquired Antithrombin III Deficiency
Intervention: Drug: Recombinant antithrombin (rhAT)

Indicates status has not been verified in more than two years